Clearpoint Neuro Inc reports results for the quarter ended in December - Earnings Summary
12/03/2024 21:52
* Clearpoint Neuro Inc CLPT.OQ reported a quarterly
adjusted
loss of 19 cents per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -18 cents. The mean expectation of three analysts for
the quarter was for a loss of 20 cents per share. Wall Street
expected results to range from -24 cents to -18 cents per share.
* Revenue rose 31.6% to $6.81 million from a year ago;
analysts
expected $6.53 million.
* Clearpoint Neuro Inc's reported EPS for the quarter was a
loss
of 19 cents.
* The company reported a quarterly loss of $4.62 million.
* Clearpoint Neuro Inc shares had fallen by 11.2% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 3.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Clearpoint Neuro
Inc is $10.00
This summary was machine generated from LSEG data March 12 at
09:52 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.20 -0.19 Beat
Sep. 30 2023 -0.25 -0.20 Beat
Jun. 30 2023 -0.19 -0.29 Missed
Mar. 31 2023 -0.18 -0.23 Missed